Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Kazanskij Medicinski...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

Опыт применения индукторов интерофероногенеза амиксина и неовира в лечении больных хроническими вирусами гепатита В и С

Опыт применения индукторов интерофероногенеза амиксина и неовира в лечении больных хроническими вирусами гепатита В и С

Abstract

The comparative clinicolaboratory study of the efficiency of using interferonogenesis inductors and a-interferon drugs is performed. It is established that a-interferon drugs are more effective in the treatment of chronic viral hepatitis B and C. However the disappearance of deoxyribonucleic HBV in chronic hepatitis B after the treatment course with amixin and neovir was recorded with approximately the same rate. Amixin significantly decreases dispepsic disorders in such patients, normalizes the intestine microflora state. In using amixin and neovir the side effects do not limit duration and success of the therapy.

Keywords

ГЕПАТИТ B, ГЕПАТИТ C, ИНТЕРФЕРОНОГЕНЫ, ИНФЕКЦИОННЫЕ БОЛЕЗНИ, ХРОНИЧЕСКАЯ БОЛЕЗНЬ, ЛЕКАРСТВЕННАЯ ТЕРАПИЯ, КОМБИНИРОВАННОЕ ЛЕЧЕБНОЕ ВОЗДЕЙСТВИЕ, ЛЕКАРСТВ ПОБОЧНОЕ ДЕЙСТВИЕ, СИСТЕМЫ ОТЧЕТОВ, СРАВНИТЕЛЬНЫЕ ИССЛЕДОВАНИЯ, ЧЕЛОВЕК, ЛЕЧЕНИЯ РЕЗУЛЬТАТОВ АНАЛИЗ

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
gold